CATCo Regulatory News (CAT)

19 May 2005 12:31

Cambridge Antibody Tech Group PLC19 May 2005 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1) Name of companyCambridge Antibody Technology 2) Name of directorJohn Stocker 3) Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of anon-beneficial interest or in the case of an individual holder if it is aholding of that person's spouse or children under the age of 18 or in respect ofa non-beneficial interestAs in 2 above 4) Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified)Greenwood Nominees Limited 5) Please state whether notification relates to a person(s) connected with the Director named in 2 above and identify the connected person(s)As in 2 above 6) Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionaryQuarterly payment of part of directors fees in lieu of cash consideration (seenotes at 23) 7) Number of shares/amount of stock acquired274 8) Percentage of issued class0.0005% 9) Number of shares/amount of stock disposedNil 10) Percentage of issued classNil 11) Class of securityOrdinary 10 pence shares 12) Price per share£5.69 13) Date of transaction19 May 2005 14) Date company informed19 May 2005 15) Total holding following this notification82,460 16) Total percentage holding of issued class following this notification0.160 If a director has been granted options by the company please complete thefollowing boxes 17) Date of grant 18) Period during which or date on which exercisable 19) Total amount paid (if any) for grant of the option 20) Description of shares or debentures involved: class, number 21) Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise 22) Total number of shares or debentures over which options held following this notification 23) Any additional informationThe practice of issuing shares in lieu of part of the basic directors fee hasbeen established by the Company for some time. In November 2004 the Boardresolved that such issue of shares would occur on a quarterly rather than anannual basis. The share price used is the average closing price of one CATshare for the three trading days preceding 19 May 2005. 24) Name of contact and telephone number for queriesJustin Hoskins, 01223 898589 25) Name and signature of authorised company official responsible for making this notification Date of Notification..19 May 2005 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1) Name of companyCambridge Antibody Technology 2) Name of director Ake Stavling 3) Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of anon-beneficial interest or in the case of an individual holder if it is aholding of that person's spouse or children under the age of 18 or in respect ofa non-beneficial interestAs in 2 above 4) Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified)Greenwood Nominees Limited 5) Please state whether notification relates to a person(s) connected with the Director named in 2 above and identify the connected person(s)As in 2 above 6) Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionaryQuarterly payment of part of directors fees in lieu of cash consideration (seenotes at 23) 7) Number of shares/amount of stock acquired274 8) Percentage of issued class0.0005% 9) Number of shares/amount of stock disposedNil 10) Percentage of issued classNil 11) Class of securityOrdinary 10 pence shares 12) Price per share£5.69 13) Date of transaction19 May 2005 14) Date company informed19 May 2005 15) Total holding following this notification2,616 16) Total percentage holding of issued class following this notification0.005% If a director has been granted options by the company please complete thefollowing boxes 17) Date of grant 18) Period during which or date on which exercisable 19) Total amount paid (if any) for grant of the option 20) Description of shares or debentures involved: class, number 21) Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise 22) Total number of shares or debentures over which options held following this notification 23) Any additional informationThe practice of issuing shares in lieu of part of the basic directors fee hasbeen established by the Company for some time. In November 2004 the Boardresolved that such issue of shares would occur on a quarterly rather than anannual basis. The share price used is the average closing price of one CATshare for the three trading days preceding 19 May 2005. 24) Name of contact and telephone number for queriesJustin Hoskins, 01223 898589 25) Name and signature of authorised company official responsible for making this notification Date of Notification..19 May 2005 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1) Name of companyCambridge Antibody Technology 2) Name of directorSir Aaron Klug 3) Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of anon-beneficial interest or in the case of an individual holder if it is aholding of that person's spouse or children under the age of 18 or in respect ofa non-beneficial interestAs in 2 above 4) Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified)Greenwood Nominees Limited 5) Please state whether notification relates to a person(s) connected with the Director named in 2 above and identify the connected person(s)As in 2 above 6) Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionaryQuarterly payment of part of directors fees in lieu of cash consideration (seenotes at 23) 7) Number of shares/amount of stock acquired274 8) Percentage of issued class0.0005% 9) Number of shares/amount of stock disposedNil 10) Percentage of issued classNil 11) Class of securityOrdinary 10 pence shares 12) Price per share£5.69 13) Date of transaction19 May 2005 14) Date company informed19 May 2005 15) Total holding following this notification28,201 16) Total percentage holding of issued class following this notification0.055% If a director has been granted options by the company please complete thefollowing boxes 17) Date of grant 18) Period during which or date on which exercisable 19) Total amount paid (if any) for grant of the option 20) Description of shares or debentures involved: class, number 21) Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise 22) Total number of shares or debentures over which options held following this notification 23) Any additional informationThe practice of issuing shares in lieu of part of the basic directors fee hasbeen established by the Company for some time. In November 2004 the Boardresolved that such issue of shares would occur on a quarterly rather than anannual basis. The share price used is the average closing price of one CATshare for the three trading days preceding 19 May 2005. 24) Name of contact and telephone number for queriesJustin Hoskins, 01223 898589 25) Name and signature of authorised company official responsible for making this notification Date of Notification..19 May 2005 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1) Name of companyCambridge Antibody Technology 2) Name of directorPeter Ringrose 3) Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of anon-beneficial interest or in the case of an individual holder if it is aholding of that person's spouse or children under the age of 18 or in respect ofa non-beneficial interestAs in 2 above 4) Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified)Greenwood Nominees Limited 5) Please state whether notification relates to a person(s) connected with the Director named in 2 above and identify the connected person(s)As in 2 above 6) Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionaryQuarterly payment of part of directors fees in lieu of cash consideration (seenotes at 23) 7) Number of shares/amount of stock acquired274 8) Percentage of issued class0.0005% 9) Number of shares/amount of stock disposedNil 10) Percentage of issued classNil 11) Class of securityOrdinary 10 pence shares 12) Price per share£5.69 13) Date of transaction19 May 2005 14) Date company informed19 May 2005 15) Total holding following this notification3,436 16) Total percentage holding of issued class following this notification0.007% If a director has been granted options by the company please complete thefollowing boxes 17) Date of grant 18) Period during which or date on which exercisable 19) Total amount paid (if any) for grant of the option 20) Description of shares or debentures involved: class, number 21) Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise 22) Total number of shares or debentures over which options held following this notification 23) Any additional informationThe practice of issuing shares in lieu of part of the basic directors fee hasbeen established by the Company for some time. In November 2004 the Boardresolved that such issue of shares would occur on a quarterly rather than anannual basis. The share price used is the average closing price of one CATshare for the three trading days preceding 19 May 2005. 24) Name of contact and telephone number for queriesJustin Hoskins, 01223 898589 25) Name and signature of authorised company official responsible for making this notification Date of Notification..19 May 2005 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1) Name of companyCambridge Antibody Technology 2) Name of directorProfessor Christopher Marshall 3) Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of anon-beneficial interest or in the case of an individual holder if it is aholding of that person's spouse or children under the age of 18 or in respect ofa non-beneficial interestAs in 2 above 4) Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified)Greenwood Nominees Limited 5) Please state whether notification relates to a person(s) connected with the Director named in 2 above and identify the connected person(s)As in 2 above 6) Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionaryQuarterly payment of part of directors fees in lieu of cash consideration (seenotes at 23) 7) Number of shares/amount of stock acquired274 8) Percentage of issued class0.0005% 9) Number of shares/amount of stock disposedNil 10) Percentage of issued classNil 11) Class of securityOrdinary 10 pence shares 12) Price per share£5.69 13) Date of transaction19 May 2005 14) Date company informed19 May 2005 15) Total holding following this notification501 16) Total percentage holding of issued class following this notification0.001% If a director has been granted options by the company please complete thefollowing boxes 17) Date of grant 18) Period during which or date on which exercisable 19) Total amount paid (if any) for grant of the option 20) Description of shares or debentures involved: class, number 21) Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise 22) Total number of shares or debentures over which options held following this notification 23) Any additional informationThe practice of issuing shares in lieu of part of the basic directors fee hasbeen established by the Company for some time. In November 2004 the Boardresolved that such issue of shares would occur on a quarterly rather than anannual basis. The share price used is the average closing price of one CATshare for the three trading days preceding 19 May 2005. 24) Name of contact and telephone number for queriesJustin Hoskins, 01223 898589 25) Name and signature of authorised company official responsible for making this notification Date of Notification..19 May 2005 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1) Name of companyCambridge Antibody Technology 2) Name of directorDr Paul Nicholson 3) Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of anon-beneficial interest or in the case of an individual holder if it is aholding of that person's spouse or children under the age of 18 or in respect ofa non-beneficial interestAs in 2 above 4) Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified)Dr Paul Nicholson 5) Please state whether notification relates to a person(s) connected with the Director named in 2 above and identify the connected person(s)As in 2 above 6) Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionaryQuarterly payment of part of directors fees in lieu of cash consideration (seenotes at 23) 7) Number of shares/amount of stock acquired659 8) Percentage of issued class0.0013% 9) Number of shares/amount of stock disposedNil 10) Percentage of issued classNil 11) Class of securityOrdinary 10 pence shares 12) Price per share£5.69 13) Date of transaction19 May 2005 14) Date company informed19 May 2005 15) Total holding following this notification10,269 16) Total percentage holding of issued class following this notification0.019% If a director has been granted options by the company please complete thefollowing boxes 17) Date of grant 18) Period during which or date on which exercisable 19) Total amount paid (if any) for grant of the option 20) Description of shares or debentures involved: class, number 21) Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise 22) Total number of shares or debentures over which options held following this notification 23) Any additional informationThe practice of issuing shares in lieu of part of the basic directors fee hasbeen established by the Company for some time. In November 2004 the Boardresolved that such issue of shares would occur on a quarterly rather than anannual basis. The share price used is the average closing price of one CATshare for the three trading days preceding 19 May 2005. 24) Name of contact and telephone number for queriesJustin Hoskins, 01223 898589 25) Name and signature of authorised company official responsible for making this notification Date of Notification..19 May 2005 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1) Name of companyCambridge Antibody Technology 2) Name of directorProfessor Uwe Bicker 3) Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of anon-beneficial interest or in the case of an individual holder if it is aholding of that person's spouse or children under the age of 18 or in respect ofa non-beneficial interestAs in 2 above 4) Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified)Professor Uwe Bicker 5) Please state whether notification relates to a person(s) connected with the Director named in 2 above and identify the connected person(s)As in 2 above 6) Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionaryQuarterly payment of part of directors fees in lieu of cash consideration (seenotes at 23) 7) Number of shares/amount of stock acquired274 8) Percentage of issued class0.0005% 9) Number of shares/amount of stock disposedNil 10) Percentage of issued classNil 11) Class of securityOrdinary 10 pence shares 12) Price per share£5.69 13) Date of transaction19 May 2005 14) Date company informed19 May 2005 15) Total holding following this notification6,319 16) Total percentage holding of issued class following this notification0.012% If a director has been granted options by the company please complete thefollowing boxes 17) Date of grant 18) Period during which or date on which exercisable 19) Total amount paid (if any) for grant of the option 20) Description of shares or debentures involved: class, number 21) Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise 22) Total number of shares or debentures over which options held following this notification 23) Any additional informationThe practice of issuing shares in lieu of part of the basic directors fee hasbeen established by the Company for some time. In November 2004 the Boardresolved that such issue of shares would occur on a quarterly rather than anannual basis. The share price used is the average closing price of one CATshare for the three trading days preceding 19 May 2005. 24) Name of contact and telephone number for queriesJustin Hoskins, 01223 898589 25) Name and signature of authorised company official responsible for making this notification Date of Notification..19 May 2005 This information is provided by RNS The company news service from the London Stock Exchange